Alkem Laboratories launches generic empagliflozin and its combinations in India under the brand name “Empanorm”
– Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure – Alkem is introducing anti-counterfeit band and important patient education information on empagliflozin packs – Alkemis offeringempagliflozin in a smaller tablet size, making it convenient for patients Alkem Laboratories Ltd (BSE: 539523, NSE: ALKEM, “Alkem” and its […]
Continue Reading